Iradimed (IRMD) Shares Outstanding (Diluted Average) (2019 - 2026)

Iradimed (IRMD) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $12.9 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) changed 0.34% year-over-year to $12.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.9 million (changed 0.34% YoY) and the FY2024 annual result came in at $12.8 million, changed 0.48% from the prior year.
• Shares Outstanding (Diluted Average) was little changed at $12.9 million in Q1 2026 per IRMD's latest filing, from $12.8 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $12.9 million in Q1 2026 and bottomed at $12.6 million in Q2 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $12.7 million (2023), against an average of $12.7 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) advanced 0.78%; it then climbed 0.21% in 2024.
• Tracing IRMD's Shares Outstanding (Diluted Average) over 5 years: stood at $12.6 million in 2022, then gained by 0.69% to $12.7 million in 2023, then advanced by 0.48% to $12.8 million in 2024, then gained by 0.46% to $12.8 million in 2025, then gained by 0.22% to $12.9 million in 2026.
• Per Business Quant, the three latest IRMD Shares Outstanding (Diluted Average) figures stand at $12.9 million (Q1 2026), $12.8 million (Q3 2025), and $12.8 million (Q2 2025).

Peer Comparison